Interaction between nitric oxide, reactive oxygen intermediates, and peroxynitrite in the regulation of 5-lipoxygenase metabolism

被引:35
作者
Coffey, MJ [1 ]
Phare, SM [1 ]
Peters-Golden, M [1 ]
机构
[1] Univ Michigan, Med Ctr, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2002年 / 1584卷 / 2-3期
关键词
leukotriene; eicosanoid; reactive oxygen intermediate; nitric oxide;
D O I
10.1016/S1388-1981(02)00286-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have shown that overnight lipopolysaccharide (LPS) suppresses alveolar macrophage (AM) leukotriene (LT) synthesis mediated in part by induction of inducible nitric oxide synthase (iNOS) and NO production. Here we examined the possibility that reactive oxygen intermediates (ROI) generated by LPS pretreatment contribute to the suppression of 5-lipoxygenase (5-LO) metabolism. Pretreatment of AM with xanthine/xanthine oxidase, which generates high concentrations of ROI, resulted in suppression of LT synthetic capacity. Since NO and ROI reactive species are known to react and form peroxynitrite (ONOO-), we examined the effect of ONOO- on 5-LO metabolism. Exogenous ONOO- caused a dose-dependent suppression of recombinant 5-LO cell-free activity. ONOO- also suppressed LT synthesis in intact AM, which was reversed by the ONOO- scavenger tetrakis(4-benzoic acid)porphyrin. ONOO- treatment also resulted in dose-dependent nitrotyrosination and S-nitrosylation of the recombinant 5-LO enzyme. Since the direct 5-LO inhibitor zileuton prevents the LPS-induced suppression of LT synthesis, we examined if 5-LO itself was the source of ROI. Zileuton reduced ROI generation in LPS-treated cells. These studies identify an important role for ROI and ONOO- in the suppression of 5-LO metabolism by LPS. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:81 / 90
页数:10
相关论文
共 50 条
[1]  
Bailie MB, 1996, J IMMUNOL, V157, P5221
[2]  
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
[3]  
BIGBY TD, 1987, J IMMUNOL, V138, P1546
[4]  
Boulos C, 2000, J PHARMACOL EXP THER, V293, P222
[5]   TRANSLOCATION AND LEUKOTRIENE SYNTHETIC CAPACITY OF NUCLEAR 5-LIPOXYGENASE IN RAT BASOPHILIC LEUKEMIA-CELLS AND ALVEOLAR MACROPHAGES [J].
BROCK, TG ;
MCNISH, RW ;
PETERSGOLDEN, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (37) :21652-21658
[6]   Nitric oxide modulation of transcellular biosynthesis of cys-leukotrienes in rabbit leukocyte-perfused heart [J].
Buccellati, C ;
Rossoni, G ;
Bonazzi, A ;
Berti, F ;
Maclouf, J ;
Folco, G ;
Sala, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (06) :1128-1134
[7]   ROLE OF LEUKOTRIENES REVEALED BY TARGETED DISRUPTION OF THE 5-LIPOXYGENASE GENE [J].
CHEN, XS ;
SHELLER, JR ;
JOHNSON, EN ;
FUNK, CD .
NATURE, 1994, 372 (6502) :179-182
[8]  
COFFEY M, 1992, J BIOL CHEM, V267, P570
[9]   INCREASES IN 5-LIPOXYGENASE ACTIVATING PROTEIN EXPRESSION ACCOUNT FOR ENHANCED CAPACITY FOR 5-LIPOXYGENASE METABOLISM THAT ACCOMPANIES DIFFERENTIATION OF PERIPHERAL-BLOOD MONOCYTES INTO ALVEOLAR MACROPHAGES [J].
COFFEY, MJ ;
WILCOXEN, SE ;
PETERSGOLDEN, M .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1994, 11 (02) :153-158
[10]  
Coffey MJ, 1996, J IMMUNOL, V157, P393